Targeting apoptosis in acute myeloid leukaemia

Acute myeloid leukaemia (AML) is a molecularly and clinically heterogeneous disease, and its incidence is increasing as the populations in Western countries age. Despite major advances in understanding the genetic landscape of AML and its impact on the biology of the disease, standard therapy has no...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassier, Philippe A, Castets, Marie, Belhabri, Amine, Vey, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674101/
https://www.ncbi.nlm.nih.gov/pubmed/29017180
http://dx.doi.org/10.1038/bjc.2017.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674101/
https://www.ncbi.nlm.nih.gov/pubmed/29017180
http://dx.doi.org/10.1038/bjc.2017.281

Ejemplares similares